Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Mephedrone designated Class B drug

By News team

Mephedrone and related compounds in the cathione group are now banned. Following recommendation from the Advisory Council on the Misuse of Drugs, the compounds are now classified as Class B drugs. The ban came into effect on 16 April 2010.

Advice from the Department of Health states that individuals who have taken the drug and have acute toxic effects should be referred to accident and emergency, whereas less severe problems should be managed symptomatically.

Citation: Clinical Pharmacist URI: 11009964

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.